Frequency and demographics of gentamicin use

Otology and Neurotology

Volumn 37, Issue 2, 2016, Pages 190-195

  Kushner, Bradley ^a   Allen, Paul D ^b   Crane, Benjamin T ^c,d  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Department of Otolaryngology ^*  (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Aminoglycosides; Dizziness; Gentamicin; Hearing loss; Human; Ototoxicity; Vestibulopathy

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ADOLESCENT; ADULT; CHILD; CLINICAL PRACTICE; FEMALE; HUMAN; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GENTAMICINS; HUMANS; INFANT; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84957846325     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000937     Document Type: Article

References (17)

1. Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 2007;15:352-7.
2. Rybak LP, Ramkumar V. Ototoxicity. Kidney Int 2007;72:931-5.
3. Chang J, Jung HH, Yang JY, et al. Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line. Hear Res 2011;282:92-6.
4. Chen Y, Huang WG, Zha DJ, et al. Aspirin attenuates gentamicin ototoxicity: From the laboratory to the clinic. Hear Res 2007; 226:178-82.
5. English WP, Williams MD. Should aminoglycoside antibiotics be abandoned? Am J Surg 2000;180:512-5.
6. Fausti SA, Henry JA, Helt WJ, et al. An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear 1999;20:497-505.
7. Fee WE Jr. Aminoglycoside ototoxicity in the human. Laryngoscope 1980;90:1-19.
8. Lerner SA, Schmitt BA, Seligsohn R, et al. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 1986;80:98-104.
9. Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des 2007;13:119-26.
10. Selimoglu E, Kalkandelen S, Erdogan F. Comparative vestibulotoxicity of different aminoglycosides in the Guinea pigs. Yonsei Med J 2003;44:517-22.
11. Ahmed RM, Hannigan IP, MacDougall HG, et al. Gentamicin ototoxicity: A 23-year selected case series of 103 patients. Med J Aust 2012;196:701-4.
12. Black FO, Pesznecker S, Stallings V. Permanent gentamicin vestibulotoxicity. Otol Neurotol 2004;25:559-69.
13. Al-Hamad A. Improving gentamicin dosing: A suggested approach to a simplified once-daily dosing schedule. J Infect Public Health 2014;7:247-8.
14. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, et al. Extended-interval aminoglycoside administration for children: A meta-analysis. Pediatrics 2004;114:e111-8.
15. Conlon BJ, Aran JM, Erre JP, et al. Attenuation of aminoglycosideinduced cochlear damage with the metabolic antioxidant alphalipoic acid. Hear Res 1999;128:40-4.
16. Song BB, Anderson DJ, Schacht J. Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo. J Pharmacol Exp Ther 1997;282:369-77.
17. Matt T, Ng CL, Lang K, et al. Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4 monosustituted 2-deoxystreptamine apramycin. PNAS 2012;109:10984-9.